TickerFactsScreenerDevelopers

Amylyx Pharmaceuticals, Inc. (AMLX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2021: -$74.80M2022: -$179.87M2023: $11.92M2024: -$167.65M2025: -$123.34M-$123.34M
2021Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$123.34M+26.4%
2024-$167.65M-1506.6%
2023$11.92M+106.6%
2022-$179.87M-140.5%
2021-$74.80M—